Nile Pharmaceuticals and Chemical Industries Company (EGX:NIPH)

EGX:NIPH Revenue

In the fiscal year ending June 30, 2026, Nile Pharmaceuticals and Chemical Industries Company had annual revenue of 2.13B EGP with 65.48% growth. Nile Pharmaceuticals and Chemical Industries Company had revenue of 216.13M in the quarter ending June 30, 2026, a decrease of -32.74%. That makes Nile Pharmaceuticals and Chemical Industries Company the 29,623rd largest company in the world by revenue and 102nd in Egypt.

• Revenue: 2.13B
• Revenue Growth: +65.48%
• P/S Ratio: 6.62
• Revenue / Employee: 853.58K
• Employees: 2,500
• Market Cap: 14.14B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	2.13B	844.36M	65.48%
Jun 30, 2025	1.29B	146.99M	12.86%
Jun 30, 2024	1.14B	137.37M	13.67%
Jun 30, 2023	1.01B	128.44M	14.65%
Jun 30, 2022	876.78M	121.27M	16.05%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error